Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,406 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 298
Recruiting: 143
Ph III recruiting: 19
Growth YoY: −14%
Industry share: 35%
Top sponsor: City of Hope Medical Center
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (273)

clinicaltrialsPublishedShowing 201–250 of 365 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07259070	Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma	recruiting	Phase 1 / Phase 2	20	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	May 13, 2026	clinicaltrials
NCT07582159	Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	not yet recruiting	Phase 2	35	City of Hope Medical CenterOTHER